Bellows A R, Grant W M
Am J Ophthalmol. 1978 May;85(5 Pt 1):615-21. doi: 10.1016/s0002-9394(14)77093-x.
Twenty-six eyes of 25 patients with chronic open-angle glaucoma and surgical aphakia with inadequate control of intraocular pressure (IOP) despite maximal medical treatment were treated with cyclocryotherapy, according to a prospective protocol and specific technique. (Neovascular and synechial glaucoma were excluded from this series.) In most cases topical medications were resumed after cyclocryotherapy. During follow-up of seven to 95 months (average, 46 months), IOP was reduced to 19 mm Hg or lower in 24 out of 26 eyes (92%). In two eyes, persistent decrease in visual acuity, unrelated to reduction of IOP, occurred after cyclocryotherapy. On the basis of the long-term benefits obtained by this procedure, we concluded that cyclocryotherapy should be considered the procedure of choice in the treatment of primary open-angle glaucoma in surgically aphakic eyes when pressure cannot be adequately reduced by maximally tolerated medical treatment.
根据一项前瞻性方案和特定技术，对25例慢性开角型青光眼且手术无晶状体眼患者的26只眼睛进行了睫状体冷凝治疗，这些患者尽管接受了最大程度的药物治疗，但眼压（IOP）控制不佳。（本系列排除新生血管性青光眼和粘连性青光眼。）在大多数情况下，睫状体冷凝治疗后恢复使用局部药物。在7至95个月（平均46个月）的随访期间，26只眼中的24只（92%）眼压降至19 mmHg或更低。有两只眼睛在睫状体冷凝治疗后出现了与眼压降低无关的视力持续下降。基于该手术获得的长期益处，我们得出结论，当最大耐受药物治疗无法充分降低眼压时，睫状体冷凝治疗应被视为手术无晶状体眼原发性开角型青光眼治疗的首选方法。
